# FDA Inspection 1293608 - Regenerative Biologics Inc. - November 18, 2025

Source: https://www.keypedia.com/records/fda_inspections/regenerative-biologics-inc/5fae3bfb-eb58-444c-9dd7-1e0146fd440d
Source feed: FDA_Inspections

> FDA Inspection 1293608 for Regenerative Biologics Inc. on November 18, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1293608
- Company Name: Regenerative Biologics Inc.
- Inspection Date: 2025-11-18
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1293608 - 2025-11-18](https://www.keypedia.com/records/fda_inspections/regenerative-biologics-inc/d706af0b-d59a-4290-b7e6-cb16bc71718a)
- [FDA Inspection 1202949 - 2023-04-13](https://www.keypedia.com/records/fda_inspections/regenerative-biologics-inc/8d74748b-73cd-45e1-9c89-d3a4e181299b)
- [FDA Inspection 1202949 - 2023-04-13](https://www.keypedia.com/records/fda_inspections/regenerative-biologics-inc/f1eebe07-ff69-4ff8-b5ba-7b7a71a0f508)
- [FDA Inspection 1202949 - 2023-04-13](https://www.keypedia.com/records/fda_inspections/regenerative-biologics-inc/70f8916a-c2b2-4581-b5b2-c16469448202)
- [FDA Inspection 1117126 - 2020-02-06](https://www.keypedia.com/records/fda_inspections/regenerative-biologics-inc/075ac2fe-be00-4567-9d2e-00a473a602c1)

Company: https://www.keypedia.com/companies/regenerative-biologics-inc/546031f7-fb56-45e9-bc3c-5c19ff0e39b4

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d